Global Custom Assays Market
Global Custom Assays Market

Custom Assays Comprehensive Study by Type (Activity Assays, Competitive Assays, Elisa Assays, Sandwich Assays, Screening Assays, Conjugation Assay, Others), Application (Academic and Research Institutes, Life Science Industries, Biotechnology Companies, Diagnostic Centers, Contract Research Organizations, Food and Beverage Companies), Technology (Flow Cytometry, Membrane Based/Planar Assays, Suspension/ Bead Based Assays, Others) Players and Region - Global Market Outlook to 2024

Custom Assays Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

May 2019 Edition 217 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Custom Assays Market Overview:
The custom assay is provided by assay kits manufacturers to customers. Custom arrays help in providing easy solutions to industrial and academic laboratories for the determination of different biological analyses such as proteins, antibodies, enzymes and many more. This market is growing significantly in emerging countries such as Japan, India, and others due to increasing numbers of research institutes. Some of the key players profiled in the study are Promega Corporation (United States), Bioassay Systems (United States), QIAGEN N.V (Germany), Sigma-Aldrich Inc. (United States), Thermo Fisher Scientific Inc. (United States), R & D Syatems Inc. (United States), BioAuxilium Research Inc. (Canada), Fluidigm (United States), Luminex Corporation (United States) and F. Hoffmann-La Roche AG (Switzerland).

On the basis of geography, the market of Custom Assays has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Flow Cytometry will boost the Custom Assays market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Rise In Research and Development Activities in Life Science and Biotechnology Industry
  • Increasing Number of Academic and Research Institutes across the Globe
  • Growing Demand for Tissue Diagnostic and Cell Based Diagnostics for Cancer, HIV, and Infectious Diseases



Opportunities
  • The Emergence of the Biochip Technology Creating Strong Opportunities for the Service Providers in the Market

Challenges
  • Optimization and Standardization Are the Factors Affecting the Growth of Global Custom Assay Market


Major Market Developments:


In Mar 2019, Ambry Genetics Announced A New Laboratory Services Agreement With Clovis Oncology Inc. To Advancing Precision Medicine For Cancer. Through This Agreement Company Can Develop Custom Assays Targeted To Patients With Hereditary Ovarian Cancer.

In This Market Major Players Are Adopting Initiatives to Achieve Organic and Inorganic Growth Strategies. Which Includes Enhancing Global Reach And Expanding Product Portfolio By Doing Merger & Acquisitions And Collaborations.

Target Audience:
Custom Assays Manufacturers, Research Institutes, Government Bodies, End Users and Others

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Custom Assays market on the basis of product [Activity Assays, Competitive Assays, Elisa Assays, Sandwich Assays, Screening Assays, Conjugation Assay and Others] , application [Academic and Research Institutes, Life Science Industries, Biotechnology Companies, Diagnostic Centers, Contract Research Organizations and Food and Beverage Companies], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Custom Assays market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Custom Assays industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Clovis Oncology Inc. (United States), BD Biosciences (United States) and Quansys Bioscience (United States).
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Custom Assays market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.
Report Objectives / Segmentation Covered
By Type
  • Activity Assays
  • Competitive Assays
  • Elisa Assays
  • Sandwich Assays
  • Screening Assays
  • Conjugation Assay
  • Others
By Application
  • Academic and Research Institutes
  • Life Science Industries
  • Biotechnology Companies
  • Diagnostic Centers
  • Contract Research Organizations
  • Food and Beverage Companies
By Technology
  • Flow Cytometry
  • Membrane Based/Planar Assays
  • Suspension/ Bead Based Assays
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise In Research and Development Activities in Life Science and Biotechnology Industry
      • 3.2.2. Increasing Number of Academic and Research Institutes across the Globe
      • 3.2.3. Growing Demand for Tissue Diagnostic and Cell Based Diagnostics for Cancer, HIV, and Infectious Diseases
    • 3.3. Market Challenges
      • 3.3.1. Optimization and Standardization Are the Factors Affecting the Growth of Global Custom Assay Market
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Custom Assays, by Type, Application, Technology and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Custom Assays (Value)
      • 5.2.1. Global Custom Assays by: Type (Value)
        • 5.2.1.1. Activity Assays
        • 5.2.1.2. Competitive Assays
        • 5.2.1.3. Elisa Assays
        • 5.2.1.4. Sandwich Assays
        • 5.2.1.5. Screening Assays
        • 5.2.1.6. Conjugation Assay
        • 5.2.1.7. Others
      • 5.2.2. Global Custom Assays by: Application (Value)
        • 5.2.2.1. Academic and Research Institutes
        • 5.2.2.2. Life Science Industries
        • 5.2.2.3. Biotechnology Companies
        • 5.2.2.4. Diagnostic Centers
        • 5.2.2.5. Contract Research Organizations
        • 5.2.2.6. Food and Beverage Companies
      • 5.2.3. Global Custom Assays by: Technology (Value)
        • 5.2.3.1. Flow Cytometry
        • 5.2.3.2. Membrane Based/Planar Assays
        • 5.2.3.3. Suspension/ Bead Based Assays
        • 5.2.3.4. Others
      • 5.2.4. Global Custom Assays Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Custom Assays: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Promega Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bioassay Systems (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. QIAGEN N.V (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sigma-Aldrich Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Thermo Fisher Scientific Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. R & D Syatems Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BioAuxilium Research Inc. (Canada)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Fluidigm (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Luminex Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. F. Hoffmann-La Roche AG (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Custom Assays Sale, by Type, Application, Technology and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Custom Assays (Value)
      • 7.2.1. Global Custom Assays by: Type (Value)
        • 7.2.1.1. Activity Assays
        • 7.2.1.2. Competitive Assays
        • 7.2.1.3. Elisa Assays
        • 7.2.1.4. Sandwich Assays
        • 7.2.1.5. Screening Assays
        • 7.2.1.6. Conjugation Assay
        • 7.2.1.7. Others
      • 7.2.2. Global Custom Assays by: Application (Value)
        • 7.2.2.1. Academic and Research Institutes
        • 7.2.2.2. Life Science Industries
        • 7.2.2.3. Biotechnology Companies
        • 7.2.2.4. Diagnostic Centers
        • 7.2.2.5. Contract Research Organizations
        • 7.2.2.6. Food and Beverage Companies
      • 7.2.3. Global Custom Assays by: Technology (Value)
        • 7.2.3.1. Flow Cytometry
        • 7.2.3.2. Membrane Based/Planar Assays
        • 7.2.3.3. Suspension/ Bead Based Assays
        • 7.2.3.4. Others
      • 7.2.4. Global Custom Assays Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Custom Assays: by Type(USD Million)
  • Table 2. Custom Assays Activity Assays , by Region USD Million (2013-2018)
  • Table 3. Custom Assays Competitive Assays , by Region USD Million (2013-2018)
  • Table 4. Custom Assays Elisa Assays , by Region USD Million (2013-2018)
  • Table 5. Custom Assays Sandwich Assays , by Region USD Million (2013-2018)
  • Table 6. Custom Assays Screening Assays , by Region USD Million (2013-2018)
  • Table 7. Custom Assays Conjugation Assay , by Region USD Million (2013-2018)
  • Table 8. Custom Assays Others , by Region USD Million (2013-2018)
  • Table 9. Custom Assays: by Application(USD Million)
  • Table 10. Custom Assays Academic and Research Institutes , by Region USD Million (2013-2018)
  • Table 11. Custom Assays Life Science Industries , by Region USD Million (2013-2018)
  • Table 12. Custom Assays Biotechnology Companies , by Region USD Million (2013-2018)
  • Table 13. Custom Assays Diagnostic Centers , by Region USD Million (2013-2018)
  • Table 14. Custom Assays Contract Research Organizations , by Region USD Million (2013-2018)
  • Table 15. Custom Assays Food and Beverage Companies , by Region USD Million (2013-2018)
  • Table 16. Custom Assays: by Technology(USD Million)
  • Table 17. Custom Assays Flow Cytometry , by Region USD Million (2013-2018)
  • Table 18. Custom Assays Membrane Based/Planar Assays , by Region USD Million (2013-2018)
  • Table 19. Custom Assays Suspension/ Bead Based Assays , by Region USD Million (2013-2018)
  • Table 20. Custom Assays Others , by Region USD Million (2013-2018)
  • Table 21. South America Custom Assays, by Country USD Million (2013-2018)
  • Table 22. South America Custom Assays, by Type USD Million (2013-2018)
  • Table 23. South America Custom Assays, by Application USD Million (2013-2018)
  • Table 24. South America Custom Assays, by Technology USD Million (2013-2018)
  • Table 25. Brazil Custom Assays, by Type USD Million (2013-2018)
  • Table 26. Brazil Custom Assays, by Application USD Million (2013-2018)
  • Table 27. Brazil Custom Assays, by Technology USD Million (2013-2018)
  • Table 28. Argentina Custom Assays, by Type USD Million (2013-2018)
  • Table 29. Argentina Custom Assays, by Application USD Million (2013-2018)
  • Table 30. Argentina Custom Assays, by Technology USD Million (2013-2018)
  • Table 31. Rest of South America Custom Assays, by Type USD Million (2013-2018)
  • Table 32. Rest of South America Custom Assays, by Application USD Million (2013-2018)
  • Table 33. Rest of South America Custom Assays, by Technology USD Million (2013-2018)
  • Table 34. Asia Pacific Custom Assays, by Country USD Million (2013-2018)
  • Table 35. Asia Pacific Custom Assays, by Type USD Million (2013-2018)
  • Table 36. Asia Pacific Custom Assays, by Application USD Million (2013-2018)
  • Table 37. Asia Pacific Custom Assays, by Technology USD Million (2013-2018)
  • Table 38. China Custom Assays, by Type USD Million (2013-2018)
  • Table 39. China Custom Assays, by Application USD Million (2013-2018)
  • Table 40. China Custom Assays, by Technology USD Million (2013-2018)
  • Table 41. Japan Custom Assays, by Type USD Million (2013-2018)
  • Table 42. Japan Custom Assays, by Application USD Million (2013-2018)
  • Table 43. Japan Custom Assays, by Technology USD Million (2013-2018)
  • Table 44. India Custom Assays, by Type USD Million (2013-2018)
  • Table 45. India Custom Assays, by Application USD Million (2013-2018)
  • Table 46. India Custom Assays, by Technology USD Million (2013-2018)
  • Table 47. South Korea Custom Assays, by Type USD Million (2013-2018)
  • Table 48. South Korea Custom Assays, by Application USD Million (2013-2018)
  • Table 49. South Korea Custom Assays, by Technology USD Million (2013-2018)
  • Table 50. Taiwan Custom Assays, by Type USD Million (2013-2018)
  • Table 51. Taiwan Custom Assays, by Application USD Million (2013-2018)
  • Table 52. Taiwan Custom Assays, by Technology USD Million (2013-2018)
  • Table 53. Australia Custom Assays, by Type USD Million (2013-2018)
  • Table 54. Australia Custom Assays, by Application USD Million (2013-2018)
  • Table 55. Australia Custom Assays, by Technology USD Million (2013-2018)
  • Table 56. Rest of Asia-Pacific Custom Assays, by Type USD Million (2013-2018)
  • Table 57. Rest of Asia-Pacific Custom Assays, by Application USD Million (2013-2018)
  • Table 58. Rest of Asia-Pacific Custom Assays, by Technology USD Million (2013-2018)
  • Table 59. Europe Custom Assays, by Country USD Million (2013-2018)
  • Table 60. Europe Custom Assays, by Type USD Million (2013-2018)
  • Table 61. Europe Custom Assays, by Application USD Million (2013-2018)
  • Table 62. Europe Custom Assays, by Technology USD Million (2013-2018)
  • Table 63. Germany Custom Assays, by Type USD Million (2013-2018)
  • Table 64. Germany Custom Assays, by Application USD Million (2013-2018)
  • Table 65. Germany Custom Assays, by Technology USD Million (2013-2018)
  • Table 66. France Custom Assays, by Type USD Million (2013-2018)
  • Table 67. France Custom Assays, by Application USD Million (2013-2018)
  • Table 68. France Custom Assays, by Technology USD Million (2013-2018)
  • Table 69. Italy Custom Assays, by Type USD Million (2013-2018)
  • Table 70. Italy Custom Assays, by Application USD Million (2013-2018)
  • Table 71. Italy Custom Assays, by Technology USD Million (2013-2018)
  • Table 72. United Kingdom Custom Assays, by Type USD Million (2013-2018)
  • Table 73. United Kingdom Custom Assays, by Application USD Million (2013-2018)
  • Table 74. United Kingdom Custom Assays, by Technology USD Million (2013-2018)
  • Table 75. Netherlands Custom Assays, by Type USD Million (2013-2018)
  • Table 76. Netherlands Custom Assays, by Application USD Million (2013-2018)
  • Table 77. Netherlands Custom Assays, by Technology USD Million (2013-2018)
  • Table 78. Rest of Europe Custom Assays, by Type USD Million (2013-2018)
  • Table 79. Rest of Europe Custom Assays, by Application USD Million (2013-2018)
  • Table 80. Rest of Europe Custom Assays, by Technology USD Million (2013-2018)
  • Table 81. MEA Custom Assays, by Country USD Million (2013-2018)
  • Table 82. MEA Custom Assays, by Type USD Million (2013-2018)
  • Table 83. MEA Custom Assays, by Application USD Million (2013-2018)
  • Table 84. MEA Custom Assays, by Technology USD Million (2013-2018)
  • Table 85. Middle East Custom Assays, by Type USD Million (2013-2018)
  • Table 86. Middle East Custom Assays, by Application USD Million (2013-2018)
  • Table 87. Middle East Custom Assays, by Technology USD Million (2013-2018)
  • Table 88. Africa Custom Assays, by Type USD Million (2013-2018)
  • Table 89. Africa Custom Assays, by Application USD Million (2013-2018)
  • Table 90. Africa Custom Assays, by Technology USD Million (2013-2018)
  • Table 91. North America Custom Assays, by Country USD Million (2013-2018)
  • Table 92. North America Custom Assays, by Type USD Million (2013-2018)
  • Table 93. North America Custom Assays, by Application USD Million (2013-2018)
  • Table 94. North America Custom Assays, by Technology USD Million (2013-2018)
  • Table 95. United States Custom Assays, by Type USD Million (2013-2018)
  • Table 96. United States Custom Assays, by Application USD Million (2013-2018)
  • Table 97. United States Custom Assays, by Technology USD Million (2013-2018)
  • Table 98. Canada Custom Assays, by Type USD Million (2013-2018)
  • Table 99. Canada Custom Assays, by Application USD Million (2013-2018)
  • Table 100. Canada Custom Assays, by Technology USD Million (2013-2018)
  • Table 101. Mexico Custom Assays, by Type USD Million (2013-2018)
  • Table 102. Mexico Custom Assays, by Application USD Million (2013-2018)
  • Table 103. Mexico Custom Assays, by Technology USD Million (2013-2018)
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Custom Assays: by Type(USD Million)
  • Table 115. Custom Assays Activity Assays , by Region USD Million (2019-2024)
  • Table 116. Custom Assays Competitive Assays , by Region USD Million (2019-2024)
  • Table 117. Custom Assays Elisa Assays , by Region USD Million (2019-2024)
  • Table 118. Custom Assays Sandwich Assays , by Region USD Million (2019-2024)
  • Table 119. Custom Assays Screening Assays , by Region USD Million (2019-2024)
  • Table 120. Custom Assays Conjugation Assay , by Region USD Million (2019-2024)
  • Table 121. Custom Assays Others , by Region USD Million (2019-2024)
  • Table 122. Custom Assays: by Application(USD Million)
  • Table 123. Custom Assays Academic and Research Institutes , by Region USD Million (2019-2024)
  • Table 124. Custom Assays Life Science Industries , by Region USD Million (2019-2024)
  • Table 125. Custom Assays Biotechnology Companies , by Region USD Million (2019-2024)
  • Table 126. Custom Assays Diagnostic Centers , by Region USD Million (2019-2024)
  • Table 127. Custom Assays Contract Research Organizations , by Region USD Million (2019-2024)
  • Table 128. Custom Assays Food and Beverage Companies , by Region USD Million (2019-2024)
  • Table 129. Custom Assays: by Technology(USD Million)
  • Table 130. Custom Assays Flow Cytometry , by Region USD Million (2019-2024)
  • Table 131. Custom Assays Membrane Based/Planar Assays , by Region USD Million (2019-2024)
  • Table 132. Custom Assays Suspension/ Bead Based Assays , by Region USD Million (2019-2024)
  • Table 133. Custom Assays Others , by Region USD Million (2019-2024)
  • Table 134. South America Custom Assays, by Country USD Million (2019-2024)
  • Table 135. South America Custom Assays, by Type USD Million (2019-2024)
  • Table 136. South America Custom Assays, by Application USD Million (2019-2024)
  • Table 137. South America Custom Assays, by Technology USD Million (2019-2024)
  • Table 138. Brazil Custom Assays, by Type USD Million (2019-2024)
  • Table 139. Brazil Custom Assays, by Application USD Million (2019-2024)
  • Table 140. Brazil Custom Assays, by Technology USD Million (2019-2024)
  • Table 141. Argentina Custom Assays, by Type USD Million (2019-2024)
  • Table 142. Argentina Custom Assays, by Application USD Million (2019-2024)
  • Table 143. Argentina Custom Assays, by Technology USD Million (2019-2024)
  • Table 144. Rest of South America Custom Assays, by Type USD Million (2019-2024)
  • Table 145. Rest of South America Custom Assays, by Application USD Million (2019-2024)
  • Table 146. Rest of South America Custom Assays, by Technology USD Million (2019-2024)
  • Table 147. Asia Pacific Custom Assays, by Country USD Million (2019-2024)
  • Table 148. Asia Pacific Custom Assays, by Type USD Million (2019-2024)
  • Table 149. Asia Pacific Custom Assays, by Application USD Million (2019-2024)
  • Table 150. Asia Pacific Custom Assays, by Technology USD Million (2019-2024)
  • Table 151. China Custom Assays, by Type USD Million (2019-2024)
  • Table 152. China Custom Assays, by Application USD Million (2019-2024)
  • Table 153. China Custom Assays, by Technology USD Million (2019-2024)
  • Table 154. Japan Custom Assays, by Type USD Million (2019-2024)
  • Table 155. Japan Custom Assays, by Application USD Million (2019-2024)
  • Table 156. Japan Custom Assays, by Technology USD Million (2019-2024)
  • Table 157. India Custom Assays, by Type USD Million (2019-2024)
  • Table 158. India Custom Assays, by Application USD Million (2019-2024)
  • Table 159. India Custom Assays, by Technology USD Million (2019-2024)
  • Table 160. South Korea Custom Assays, by Type USD Million (2019-2024)
  • Table 161. South Korea Custom Assays, by Application USD Million (2019-2024)
  • Table 162. South Korea Custom Assays, by Technology USD Million (2019-2024)
  • Table 163. Taiwan Custom Assays, by Type USD Million (2019-2024)
  • Table 164. Taiwan Custom Assays, by Application USD Million (2019-2024)
  • Table 165. Taiwan Custom Assays, by Technology USD Million (2019-2024)
  • Table 166. Australia Custom Assays, by Type USD Million (2019-2024)
  • Table 167. Australia Custom Assays, by Application USD Million (2019-2024)
  • Table 168. Australia Custom Assays, by Technology USD Million (2019-2024)
  • Table 169. Rest of Asia-Pacific Custom Assays, by Type USD Million (2019-2024)
  • Table 170. Rest of Asia-Pacific Custom Assays, by Application USD Million (2019-2024)
  • Table 171. Rest of Asia-Pacific Custom Assays, by Technology USD Million (2019-2024)
  • Table 172. Europe Custom Assays, by Country USD Million (2019-2024)
  • Table 173. Europe Custom Assays, by Type USD Million (2019-2024)
  • Table 174. Europe Custom Assays, by Application USD Million (2019-2024)
  • Table 175. Europe Custom Assays, by Technology USD Million (2019-2024)
  • Table 176. Germany Custom Assays, by Type USD Million (2019-2024)
  • Table 177. Germany Custom Assays, by Application USD Million (2019-2024)
  • Table 178. Germany Custom Assays, by Technology USD Million (2019-2024)
  • Table 179. France Custom Assays, by Type USD Million (2019-2024)
  • Table 180. France Custom Assays, by Application USD Million (2019-2024)
  • Table 181. France Custom Assays, by Technology USD Million (2019-2024)
  • Table 182. Italy Custom Assays, by Type USD Million (2019-2024)
  • Table 183. Italy Custom Assays, by Application USD Million (2019-2024)
  • Table 184. Italy Custom Assays, by Technology USD Million (2019-2024)
  • Table 185. United Kingdom Custom Assays, by Type USD Million (2019-2024)
  • Table 186. United Kingdom Custom Assays, by Application USD Million (2019-2024)
  • Table 187. United Kingdom Custom Assays, by Technology USD Million (2019-2024)
  • Table 188. Netherlands Custom Assays, by Type USD Million (2019-2024)
  • Table 189. Netherlands Custom Assays, by Application USD Million (2019-2024)
  • Table 190. Netherlands Custom Assays, by Technology USD Million (2019-2024)
  • Table 191. Rest of Europe Custom Assays, by Type USD Million (2019-2024)
  • Table 192. Rest of Europe Custom Assays, by Application USD Million (2019-2024)
  • Table 193. Rest of Europe Custom Assays, by Technology USD Million (2019-2024)
  • Table 194. MEA Custom Assays, by Country USD Million (2019-2024)
  • Table 195. MEA Custom Assays, by Type USD Million (2019-2024)
  • Table 196. MEA Custom Assays, by Application USD Million (2019-2024)
  • Table 197. MEA Custom Assays, by Technology USD Million (2019-2024)
  • Table 198. Middle East Custom Assays, by Type USD Million (2019-2024)
  • Table 199. Middle East Custom Assays, by Application USD Million (2019-2024)
  • Table 200. Middle East Custom Assays, by Technology USD Million (2019-2024)
  • Table 201. Africa Custom Assays, by Type USD Million (2019-2024)
  • Table 202. Africa Custom Assays, by Application USD Million (2019-2024)
  • Table 203. Africa Custom Assays, by Technology USD Million (2019-2024)
  • Table 204. North America Custom Assays, by Country USD Million (2019-2024)
  • Table 205. North America Custom Assays, by Type USD Million (2019-2024)
  • Table 206. North America Custom Assays, by Application USD Million (2019-2024)
  • Table 207. North America Custom Assays, by Technology USD Million (2019-2024)
  • Table 208. United States Custom Assays, by Type USD Million (2019-2024)
  • Table 209. United States Custom Assays, by Application USD Million (2019-2024)
  • Table 210. United States Custom Assays, by Technology USD Million (2019-2024)
  • Table 211. Canada Custom Assays, by Type USD Million (2019-2024)
  • Table 212. Canada Custom Assays, by Application USD Million (2019-2024)
  • Table 213. Canada Custom Assays, by Technology USD Million (2019-2024)
  • Table 214. Mexico Custom Assays, by Type USD Million (2019-2024)
  • Table 215. Mexico Custom Assays, by Application USD Million (2019-2024)
  • Table 216. Mexico Custom Assays, by Technology USD Million (2019-2024)
  • Table 217. Research Programs/Design for This Report
  • Table 218. Key Data Information from Secondary Sources
  • Table 219. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Custom Assays: by Type USD Million (2013-2018)
  • Figure 5. Global Custom Assays: by Application USD Million (2013-2018)
  • Figure 6. Global Custom Assays: by Technology USD Million (2013-2018)
  • Figure 7. South America Custom Assays Share (%), by Country
  • Figure 8. Asia Pacific Custom Assays Share (%), by Country
  • Figure 9. Europe Custom Assays Share (%), by Country
  • Figure 10. MEA Custom Assays Share (%), by Country
  • Figure 11. North America Custom Assays Share (%), by Country
  • Figure 12. Global Custom Assays share by Players 2018 (%)
  • Figure 13. Global Custom Assays share by Players (Top 3) 2018(%)
  • Figure 14. Global Custom Assays share by Players (Top 5) 2018(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Promega Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 17. Promega Corporation (United States) Revenue: by Geography 2018
  • Figure 18. Bioassay Systems (United States) Revenue, Net Income and Gross profit
  • Figure 19. Bioassay Systems (United States) Revenue: by Geography 2018
  • Figure 20. QIAGEN N.V (Germany) Revenue, Net Income and Gross profit
  • Figure 21. QIAGEN N.V (Germany) Revenue: by Geography 2018
  • Figure 22. Sigma-Aldrich Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Sigma-Aldrich Inc. (United States) Revenue: by Geography 2018
  • Figure 24. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2018
  • Figure 26. R & D Syatems Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. R & D Syatems Inc. (United States) Revenue: by Geography 2018
  • Figure 28. BioAuxilium Research Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 29. BioAuxilium Research Inc. (Canada) Revenue: by Geography 2018
  • Figure 30. Fluidigm (United States) Revenue, Net Income and Gross profit
  • Figure 31. Fluidigm (United States) Revenue: by Geography 2018
  • Figure 32. Luminex Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. Luminex Corporation (United States) Revenue: by Geography 2018
  • Figure 34. F. Hoffmann-La Roche AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 35. F. Hoffmann-La Roche AG (Switzerland) Revenue: by Geography 2018
  • Figure 36. Global Custom Assays: by Type USD Million (2019-2024)
  • Figure 37. Global Custom Assays: by Application USD Million (2019-2024)
  • Figure 38. Global Custom Assays: by Technology USD Million (2019-2024)
  • Figure 39. South America Custom Assays Share (%), by Country
  • Figure 40. Asia Pacific Custom Assays Share (%), by Country
  • Figure 41. Europe Custom Assays Share (%), by Country
  • Figure 42. MEA Custom Assays Share (%), by Country
  • Figure 43. North America Custom Assays Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Promega Corporation (United States)
  • Bioassay Systems (United States)
  • QIAGEN N.V (Germany)
  • Sigma-Aldrich Inc. (United States)
  • Thermo Fisher Scientific Inc. (United States)
  • R & D Syatems Inc. (United States)
  • BioAuxilium Research Inc. (Canada)
  • Fluidigm (United States)
  • Luminex Corporation (United States)
  • F. Hoffmann-La Roche AG (Switzerland)
Additional players considered in the study are as follows:
Clovis Oncology Inc. (United States) , BD Biosciences (United States) , Quansys Bioscience (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation